What are the treatment options for nummular eczema?

Treatment of Nummular Eczema

Treat nummular eczema as a variant of atopic dermatitis using high-potency topical corticosteroids under occlusion as first-line therapy, combined with aggressive emollient use and skin barrier support. 1, 2

Understanding Nummular Eczema

Nummular eczema is now recognized as a distinct phenotype of atopic dermatitis with a codominant TH2/TH17 immune response, rather than a separate disease entity. 3 This classification is critical because it directs treatment toward type 2 immunity as the primary therapeutic target. 3

First-Line Topical Therapy

Emollients and Skin Barrier Support

• Apply emollients immediately after bathing to create a surface lipid film that prevents transepidermal water loss. 4
• Use soap-free cleansers or dispersable creams as soap substitutes, since regular soaps remove natural skin lipids that are already deficient in atopic dermatitis. 4
• Bathe in warm water for at least 10 minutes using neutral pH, fragrance-free hypoallergenic cleansers. 4

Topical Corticosteroids

• Use high-potency or ultra-high potency topical corticosteroids as the mainstay of therapy for nummular eczema. 1, 2
• For trunk and extremity lesions (the most common sites), apply medium-to-high potency TCS such as betamethasone dipropionate 0.05% once or twice daily for 2-4 weeks. 5, 2
• Apply topical corticosteroids under occlusion to enhance penetration and efficacy in these characteristically thick, coin-shaped plaques. 1
• For facial lesions (rare in nummular eczema), use only low-potency agents like hydrocortisone 1-2.5%. 4, 5

Proactive Maintenance

• After flare resolution, apply topical corticosteroids twice weekly to previously affected sites to reduce relapse risk. 5
• Continue liberal emollient use throughout treatment and maintenance phases. 5

Second-Line Topical Options

When first-line therapy provides inadequate control after 2-4 weeks:

• Topical calcineurin inhibitors (tacrolimus 0.1% or pimecrolimus 1%) can be used as steroid-sparing agents, particularly for maintenance therapy. 5
• Topical JAK inhibitors (ruxolitinib cream) have moderate-certainty evidence for efficacy. 5
• Topical PDE-4 inhibitors (crisaborole) have high-certainty evidence for mild-to-moderate disease. 5

Systemic Therapy for Severe or Refractory Disease

Dupilumab (First-Line Systemic Agent)

• Dupilumab is the preferred first-line systemic agent for nummular eczema that fails topical therapy. 4, 6
• In a multicenter study of 30 adults with nummular-like atopic dermatitis, dupilumab showed significant improvement in EASI, pruritus VAS, and DLQI scores after 16 weeks. 6
• This efficacy is explained by nummular eczema's predominant type 2 immune signature, making IL-4/IL-13 blockade highly effective. 3
• Conjunctivitis is the primary side effect to monitor. 6

Methotrexate (Alternative Systemic Option)

• For children with severe nummular eczema failing topical therapy, methotrexate is effective and well-tolerated. 7
• In a retrospective study of 28 children, 82.1% achieved marked-to-complete improvement (>50% clearance) with median treatment duration of 12.6 months. 7
• Gastrointestinal intolerance (21.4%) and mild liver enzyme elevation (17.9%) are the most common side effects. 7

What NOT to Do

• Do not use topical antihistamines—they have little to no value in atopic dermatitis and are not recommended. 4, 5
• Do not use topical antimicrobials routinely—reserve them only for clinically evident secondary bacterial infection (crusting, weeping, honey-colored exudate). 4, 5
• Do not use systemic corticosteroids except as short-term bridge therapy for severe acute exacerbations; they are not appropriate for chronic management. 4, 5
• Do not use low-potency corticosteroids initially—nummular eczema requires high-potency agents due to the thick, persistent nature of the plaques. 1, 2

Identifying and Managing Triggers

• Identify and avoid specific irritants through careful history-taking. 4
• Avoid extremes of temperature, which can exacerbate eczema. 4
• Keep nails short to minimize damage from scratching. 4
• Perform potassium hydroxide wet-mount examination if tinea corporis is suspected, as annular fungal infections can mimic nummular eczema. 2
• Consider patch testing in patients with chronic, recalcitrant nummular eczema, as contact allergy is common. 2

Clinical Pearls

The key distinction in treating nummular eczema versus classic atopic dermatitis is the need for more potent topical corticosteroids under occlusion due to the thick, lichenified nature of the coin-shaped plaques. 1 Many patients eventually require systemic immunomodulatory agents despite optimal topical therapy. 1 The molecular evidence supporting nummular eczema as an atopic dermatitis variant validates the use of dupilumab and other type 2-targeted therapies. 3